1 Min Read
June 29 (Reuters) - Oncolytics Biotech Inc
* Oncolytics biotech inc. announces phase 2 study in female patients with colorectal cancer metastatic to the liver Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.